title: Should the c100 antigen be removed from HCV antibody assays?
authors.forename: H L
authors.initials: HL
authors.lastname: Zaaijer
authors.forename: H T
authors.initials: HT
authors.lastname: Cuypers
authors.forename: H W
authors.initials: HW
authors.lastname: Reesink
authors.forename: P N
authors.initials: PN
authors.lastname: Lelie
mesh_terms: D000956:Antigens, Viral; D004797:Enzyme-Linked Immunosorbent Assay; D016174:Hepacivirus / Q000276:immunology* / Q000302:isolation & purification; D006508:Hepatitis Antibodies / Q000097:blood* / Q000276:immunology; D006526:Hepatitis C / Q000175:diagnosis / Q000517:prevention & control*; D018937:Hepatitis C Antibodies; D006801:Humans; D015151:Immunoblotting; D008403:Mass Screening / Q000379:methods*; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000097:blood; D012680:Sensitivity and Specificity; D017361:Viral Nonstructural Proteins / Q000276:immunology*
chemical_list: D000956:Antigens, Viral; C064544:C100 protein, hepatitis C virus; D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies; D012367:RNA, Viral; D017361:Viral Nonstructural Proteins